Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05215340 |
|---|---|
| Brief Title: | Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (TROPION-Lung08) |
| First Submitted : | January 18, 2022 |
| First Submitted that Met QC Criteria : | January 18, 2022 |
| First Posted : | January 31, 2022 |
| Last Update Submitted that Met QC Criteria : | April 16, 2024 |
| Last Update Posted : | April 17, 2024 |